Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
ABSTRACT
In order to see the functionality and toxicity of nanoparticles in considered as process parameters to be optimized. The effect
various food and drug applications, it is important to establish of the process parameters on size of the nanoparticles was
procedures to prepare nanoparticles of a controlled size. studied. The results indicated that the size control of BSA
Desolvation is a thermodynamically driven self-assembly nanoparticles was achieved by adding acetone intermittently.
process for polymeric materials. In this study, we prepared The standard deviation of average size of BSA nanoparticles at
BSA nanoparticles using the desolvation technique using each preparation condition was minimized by adding acetone
acetone as desolvating agent. Acetone was added intermittently. The intermittent addition in polymeric aqueous
intermittently into 1% BSA solution at different pH under solution can be useful for size control for food or drug
stirring at 700 rpm. Amount of acetone added, intermittent applications.
timeline of acetone addition, and pH of solution were
KEYWORDS: Desolvating agent; particle size; drug interaction; aspirin; polymeric nanoparticles.
1643
1644 Int J Pharm Sci Nanotech Vol 5;Issue 1AprilJune 2012
suspension colloidal and hence milky in appearance. continuously in the solution with rate addition about 1.0
Both lipophylic and hydrophilic drugs can be entrapped to 2.0 ml per minute and for intermittent method 2 ml of
in nanoparticles using this technique. acetone was added for every 5 minutes interval. Then a
The main purpose of this study was to prepare few ml of 6% glutaraldehyde solution was added drop
aspirin loaded BSA nanoparticles using the desolvation wise and kept for stirring for 12 hours. Then the solvent
technique using continuous and intermittent addition of was removed in rotary flash vacuum evaporator. The
acetone as desolvating agent. The effect of continuous nanoparticles so obtained are kept for air drying
and intermittent addition of acetone on resultant (Dongmei Zhao et al., 2010).
nanoparticle size was studied.
Results and Discussion
Determining the Size of Nanoparticles
Materials and Methods
The size of the gelatin nanoparticles was determined
Chemicals by a scanning electron microscope (Maghsoudi et al.,
2008). In order to perform the SEM observation,
BSA (Bovine serum albumin) was commercially
nanoparticle suspension was first diluted with ultrapure
supplied from Sigma Aldrich (St. Louis MO, USA).
water (1/5), and then a drop of the diluted nanoparticle
Analytical Grade high purity acetone was supplied from
suspension was then directly deposited on a polished
Fisher Scientifics.
aluminum sample holder. Samples were dried in a
vacuum. The morphology of nanoparticles was observed
Methodology
at 15 kV using a scanning electron microscope (SEM; S-
BSA nanoparticles were prepared using the 3700 N, Hitachi, Japan) (Truong-Le et al., 1999). The
desolvation method (Langer K et al., 2003). BSA powder images of nanoparticles prepared by the continuous
was added to distilled water. Acetone was added addition method are illustrated in Figure 1 and Figure 2.
continuously or intermittently into 1% BSA solution at The images of the nanoparticles prepared by the
pH 7 under stirring at 700 rpm at room temperature intermittent addition method were illustrated in Figure
until the solution became just turbid. Here BSA 3 and Figure 4.
nanoparticles were prepared by two methods: 1)
Continuous addition and 2) Intermittent addition. In
continuous addition method acetone was added
Fourier Transforms Infrared Spectroscopy (FT-IR) 800 Mpa. Commercial dies were available and the
The FT-IR spectra acquired were taken for the dried manufacturers instructions were strictly followed. The
samples (Figure 5 and Figure 6). An FT-IR (7000) resultant disc was mounted in a suitable holder in the
spectrometer was used for the analysis in the frequency spectrophotometer. The IR spectra of the sample were
range between 4000-400 cm-1. It is made as described determined from 600-4400 cm-1. Several factors, such as
below. About 1 mg of the substance was trituated with inadequate or excessive grinding, moisture or other
approximately 300 mg of dry and finely powdered impurities in the halide carrier, may have given rise to
potassium bromide IR. These quantities are usually unsatisfactory discs. A disc should be rejected if visual
suitable for a disc 13 mm in diameter. The mixture was inspection shows a lack of uniformity or transmittance at
thoroughly granded, spread out uniformly in a suitable about 2000 cm-1 (5 m) in the absence of a specific
die and compressed under vacuum at a pressure of about absorption band is less than 75% without compensation.
Conclusions Coester C.J., Langer K., Van Briesen H. and Kreuter J. (2000). Gelatin
nanoparticles by two-step desolvation-a new preparation method,
BSA nanoparticles are prepared by the continuous or surface modifications and cell uptake. J Microencapsul 17: 187-193.
intermittent addition of acetone as desolvating agent. Dongmei Zhao, Xiuhua Zhao, Yuangang Zu and Jialei Li (2010).
Effect of the process parameters such as amount of Preparation, characterization, and in vitro targeted delivery of folate-
decorated paclitaxel-loadedbovine serum albumin nanoparticles. Int
acetone added, intermittent timeline of acetone addition, J Nanomedicine 5: 669677.
and pH of solution on the size of the nanoparticles was Jahanshahi M., Najafpour G. and Rahimnejad M. (2008). Applying the
studied. The results indicated that the size control of Taguchi method for optimized fabrication of bovine serum albumin
BSA nanoparticle was achieved by adding acetone (BSA) nanoparticles as drug delivery vehicles. Afr J Biotech 7(4):
362-367.
intermittently. The standard deviation of the average Jahanshahi M. and Babaei Z. (2008). Protein nanoparticle: A unique
size of BSA nanoparticles at each preparation condition system as drug delivery vehicles. African J Biotech 7(25): 4926-4934.
was minimized by adding acetone intermittently. FTIR Langer K., Balthasar S., Vogel V., Dinauer N., Von Briesen H. and
spectra indicated that there is no polymer drug Schubert D. (2003). Optimization of the preparation process for
human serum albumin (HSA) nanoparticles. International Journal of
interaction. Further studies can be performed on drug Pharmaceutics 257(1-2): 169-180.
encapsulation efficiency and in vitro release of drug from Mller B.G., Leuenberger H. and Kissel T. (1996). Albumin nanospheres
polymeric nanoparticles. as carriers for passive drug targeting: An optimized manufacturing
technique. Pharma Res 13(1):32-37.
Mohanraj V.J. and Chen Y. (2006). Nanoparticles-A Review. Trop J
Acknowledgements Pharm Res 5(1): 561-573.
Rahimnejad M. and Jahanshahi G.D. (2006). Production of biological
This work has been financially supported by UGC nanoparticles from bovin serum albumin for drug delivery. African J
(University Grants commission), New Delhi, India. Biotech 5 (20): 1918-1923.
Truong-Le V.L., Walsh S.M., Guggino W.B., August J.T. and Leong K.W.
(1999). Gene transfer by DNA-Gelatin nanospheres, Arch Biochem
References Biophys 361(1): 47-56.
Azarmi S.H., Huang Y., Chen H., McQuarrie S., Abrams D., Roa W., Weber C., Coester C., Kreuter J. and Langer K. (2000). Desolvation
Finlay W.H., Miller G.G. and Lbenberg R. (2006). Optimization of a process and surface characterisation of protein nanoparticles. Int J
two-step desolvation method for preparing gelatin nanoparticles and Pharmaceutics 194(1): 91-102.
cell uptake studies in 143B osteosarcoma cancer cells. J Pharm
Pharmaceut Sci 9(1): 124-132. Address correspondence to: A. Krishna Sailaja, Faculty of Technology,
Maghsoudi A., Shojaosadati S.A. and Farahani E.V. (2008). 5- Osmania University Hyderabad, India. Mob:+91-9440182572
Fluorouracil-loaded BSA nanoparticles: Formulation optimization E-mail: shailaja1234@rediffmail.com
and in vitro release study. AAPS Pharm Sci Tech 9(4): 1092-1096.